Where does BioMedtrix, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioMedtrix, LLC ranks #34,495 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioMedtrix, LLC hold?

BioMedtrix, LLC holds 7 US utility patents granted between 2017 and 2024, spanning 8 technology areas.

What is BioMedtrix, LLC's Innovation Score?

BioMedtrix, LLC has an Innovation Score of 34.4 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does BioMedtrix, LLC focus on?

BioMedtrix, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 5 patents, ranking #3,118 of 7,127 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is BioMedtrix, LLC's patent grant rate increasing or decreasing?

BioMedtrix, LLC's recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for BioMedtrix, LLC's patents?

BioMedtrix, LLC's patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioMedtrix, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BioMedtrix, LLC

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biomedtrix ranks #34,495 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#34,495
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.4/100): 17.6
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34495 · US Corporation #34,495 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,495/49,997
PHOTO-FINISH Bio-Thera Solutions
CPC-NARROW A61B · 8 areas
INNOV-THIN 34.4/100
CLAIMS-RICH 17.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bio-Thera Solutions, Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biomedtrix’s 34.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (21%) Velocity 6.7 pts (19%) Breadth 10.0 pts (29%) Claim depth 10.5 pts (31%)

Qualcomm Incorporated · highest

85
BioMedtrix · this assignee

34
3D Lighting… · lowest

7

What this shows Biomedtrix's Innovation Score is 34.4/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biomedtrix?

Each dot is one of Biomedtrix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biomedtrix’s own 17.6 claims/patent is at or below the 20.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biomedtrix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biomedtrix's grants concentrate

BioMedtrix, LLC is a focused PatentsView assignee: 8 CPC subclasses with 71.4% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2017. By volume, Biomedtrix sits between Bio Tillion, LLC and BioSure North America LLC.

Biomedtrix's three-year grant acceleration

BioMedtrix, LLC shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bio Tillion

7
Bio-thera Solutio…

7
Biochemics

7
Biocircuit

7
Biomimetix JV

7
Biontech Cell & G…

7
Biostem

7
Biosure North Ame…

7
Biomedtrix ◀

7

What this shows BioMedtrix holds 7 patents at rank #34,536, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioMedtrix

By rank, the assignees closest to #34,536 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in BioMedtrix's primary technology class.

Biomedtrix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

BioMedtrix, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	14.3%
2019	1	14.3%
2020	1	14.3%
2021	1	14.3%
2023	2	28.6%
2024	1	14.3%

Which technologies does BioMedtrix, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

B26B - Hand-held Cutting Tools NOT Otherwise Provided FOR 2

B23D - PLANING; SLOTTING; SHEARING; BROACHING; SAWING; FILING; SCRAPING; Like Operations FOR Working Metal BY Removing Material, NOT Otherwise Provided FOR 2

B26D - CUTTING; Details Common TO Machines FOR Perforating, Punching, Cutting-out, Stamping-out OR Severing 2

Y10T - Technical Subjects Covered BY Former US Classification 2

A61D - Veterinary Instruments, Implements, Tools, OR Methods 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BioMedtrix, LLC's patent record in context - here's where to go next.

BioMedtrix, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 71.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #34,495 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioMedtrix, LLC against Bio Tillion, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.